← Eichor
Study identifier: NCT06241651 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

CSP Versus BiVP for Heart Failure Patients With RVP Upgraded to Cardiac Resynchronization Therapy

Condition: Conduction System Pacing · Biventricular Pacing · Cardiac Resynchronization Therapy  ·  Sponsor: The First Affiliated Hospital with Nanjing Medical University

PhaseNA
Planned participants66
Who can joinAll sexes, 18 Years to 80 Years
Healthy volunteersNo

About this study

The present study is a prospective, multicenter, non-inferiority, randomized controlled trail. It aims to investigate whether the efficacy of conduction system pacing (CSP) is non-inferior to biventricular pacing (BiVP) in patients with heart failure and right ventricular pacing (RVP) requiring upgrading to cardiac resynchronization therapy (CRT).

This description comes directly from the study's public registry record.

Talk to the study team

Jiangang Zou  ·  86-13605191407  ·  jgzou@njmu.edu.cn

Always discuss trial participation with your own doctor first.

Locations (1)

The First Affiliated Hospital with Nanjing Medical UniversityNanjing, Jiangsu, ChinaRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06241651